Enhanced Akt phosphorylation and myogenic differentiation in PI3K p110β-deficient myoblasts is mediated by PI3K p110α and mTORC2

References

• Adams GR. 2006. Satellite cell proliferation and skeletal muscle hypertrophy. Appl Physiol Nutr Metab. 31:782–790.
   Google Scholar
• Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P, Hemmings BA. 1996. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15:6541–6551.
   PubMed Web of Science ®Google Scholar
• Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PR, Reese CB, Cohen P. 1997. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr Biol. 7:261–269.
   PubMed Web of Science ®Google Scholar
• Barnett SF, Defeo-Jones D, Fu S, Hancock PJ, Haskell KM, Jones RE, Kahana JA, Kral AM, Leander K, Lee LL, Malinowski J, McAvoy EM, Nahas DD, Robinson RG, Huber HE. 2005. Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors. Biochem J. 385:399–408.
   PubMed Web of Science ®Google Scholar
• Bentzinger CF, Romanino K, Cloetta D, Lin S, Mascarenhas JB, Oliveri F, Xia J, Casanova E, Costa CF, Brink M, Zorzato F, Hall MN, Ruegg MA. 2008. Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab. 8:411–424.
   PubMed Web of Science ®Google Scholar
• Boulbes DR, Shaiken T, Sarbassov dos D. 2011. Endoplasmic reticulum is a main localization site of mTORC2. Biochem Biophys Res Commun. 413:46–52.
   Google Scholar
• Bozulic L, Surucu B, Hynx D, Hemmings BA. 2008. PKBalpha/Akt1 acts downstream of DNA-PK in the DNA double-strand break response and promotes survival. Mol Cell. 30:203–213.
   PubMed Web of Science ®Google Scholar
• Brachmann SM, Ueki K, Engelman JA, Kahn RC, Cantley LC. 2005. Phosphoinositide 3-kinase catalytic subunit deletion and regulatory subunit deletion have opposite effects on insulin sensitivity in mice. Mol Cell Biol. 25:1596–1607.
   PubMedGoogle Scholar
• Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:248–254.
   PubMed Web of Science ®Google Scholar
• Brodbeck D, Cron P, Hemmings BA. 1999. A human protein kinase Bgamma with regulatory phosphorylation sites in the activation loop and in the C-terminal hydrophobic domain. J Biol Chem. 274:9133–9136.
   PubMed Web of Science ®Google Scholar
• Brognard J, Sierecki E, Gao T, Newton AC. 2007. PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Mol Cell. 25:917–931.
   PubMed Web of Science ®Google Scholar
• Charge SB, Rudnicki MA. 2004. Cellular and molecular regulation of muscle regeneration. Physiol Rev. 84:209–238.
   PubMed Web of Science ®Google Scholar
• Cho H, Thorvaldsen JL, Chu Q, Feng F, Birnbaum MJ. 2001. Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem. 276:38349–38352.
   PubMed Web of Science ®Google Scholar
• Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw EB3rd., Kaestner KH, Bartolomei MS, Shulman GI, Birnbaum MJ. 2001. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science. 292:1728–1731.
   PubMed Web of Science ®Google Scholar
• Ciraolo E, Iezzi M, Marone R, Marengo S, Curcio C, Costa C, Azzolino O, Gonella C, Rubinetto C, Wu H, Dastru W, Martin EL, Silengo L, Altruda F, Turco E, Lanzetti L, Musiani P, Ruckle T, Rommel C, Backer JM, Forni G, Wymann MP, Hirsch E. 2008. Phosphoinositide 3-kinase p110beta activity: Key role in metabolism and mammary gland cancer but not development. Sci Signal. 1:ra3.
   PubMed Web of Science ®Google Scholar
• Copp J, Manning G, Hunter T. 2009. TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): Phospho-Ser2481 is a marker for intact mTOR signaling complex 2. Cancer Res. 69:1821–1827.
   PubMed Web of Science ®Google Scholar
• Dalle Pezze P, Sonntag AG, Thien A, Prentzell MT, Godel M, Fischer S, Neumann-Haefelin E, Huber TB, Baumeister R, Shanley DP, Thedieck K. 2012. A dynamic network model of mTOR signaling reveals TSC-independent mTORC2 regulation. Sci Signal. 5:ra25.
   PubMed Web of Science ®Google Scholar
• Easton RM, Cho H, Roovers K, Shineman DW, Mizrahi M, Forman MS, Lee VM, Szabolcs M, de Jong R, Oltersdorf T, Ludwig T, Efstratiadis A, Birnbaum MJ. 2005. Role for Akt3/protein kinase Bgamma in attainment of normal brain size. Mol Cell Biol. 25:1869–1878.
   PubMed Web of Science ®Google Scholar
• Ewton DZ, Florini JR. 1981. Effects of the somatomedins and insulin on myoblast differentiation in vitro. Dev Biol. 86:31–39.
   PubMedGoogle Scholar
• Feldman ME, Apsel B, Uotila A, Loewith R, Knight ZA, Ruggero D, Shokat KM. 2009. Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. PLoS Biol. 7:e38.
   PubMed Web of Science ®Google Scholar
• Feng J, Park J, Cron P, Hess D, Hemmings BA. 2004. Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase. J Biol Chem. 279:41189–41196.
   PubMed Web of Science ®Google Scholar
• Florini JR, Magri KA, Ewton DZ, James PL, Grindstaff K, Rotwein PS. 1991. “Spontaneous” differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II. J Biol Chem. 266:15917–15923.
   PubMed Web of Science ®Google Scholar
• Foukas LC, Shepherd PR. 2004. Phosphoinositide 3-kinase: The protein kinase that time forgot. Biochem Soc Trans. 32:330–331.
   PubMedGoogle Scholar
• Foukas LC, Claret M, Pearce W, Okkenhaug K, Meek S, Peskett E, Sancho S, Smith AJ, Withers DJ, Vanhaesebroeck B. 2006. Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation. Nature. 441:366–370.
   PubMed Web of Science ®Google Scholar
• Franke TF, Kaplan DR, Cantley LC, Toker A. 1997. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science. 275:665–668.
   PubMed Web of Science ®Google Scholar
• Frias MA, Thoreen CC, Jaffe JD, Schroder W, Sculley T, Carr SA, Sabatini DM. 2006. mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s. Curr Biol. 16:1865–1870.
   PubMed Web of Science ®Google Scholar
• Gan X, Wang J, Su B, Wu D. 2011. Evidence for direct activation of mTORC2 kinase activity by phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem. 286:10998–11002.
   PubMed Web of Science ®Google Scholar
• Gao T, Furnari F, Newton AC. 2005. PHLPP: A phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol Cell. 18:13–24.
   PubMed Web of Science ®Google Scholar
• Guillermet-Guibert J, Bjorklof K, Salpekar A, Gonella C, Ramadani F, Bilancio A, Meek S, Smith AJ, Okkenhaug K, Vanhaesebroeck B. 2008. The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma. Proc Natl Acad Sci USA. 105:8292–8297.
   PubMed Web of Science ®Google Scholar
• Guo JP, Coppola D, Cheng JQ. 2011. IKBKE protein activates Akt independent of phosphatidylinositol 3-kinase/PDK1/mTORC2 and the pleckstrin homology domain to sustain malignant transformation. J Biol Chem. 286:37389–37398.
   PubMed Web of Science ®Google Scholar
• Halevy O, Cantley LC. 2004. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells. Exp Cell Res. 297:224–234.
   PubMed Web of Science ®Google Scholar
• Hayakawa M, Kaizawa H, Moritomo H, Koizumi T, Ohishi T, Okada M, Ohta M, Tsukamoto S, Parker P, Workman P, Waterfield M. 2006. Synthesis and biological evaluation of 4-morpholino-2-phenylquinazolines and related derivatives as novel PI3 kinase p110alpha inhibitors. Bioorg Med Chem. 14:6847–6858.
   PubMed Web of Science ®Google Scholar
• Hill MM, Feng J, Hemmings BA. 2002. Identification of a plasma membrane Raft-associated PKB Ser473 kinase activity that is distinct from ILK and PDK1. Curr Biol. 12:1251–1255.
   PubMed Web of Science ®Google Scholar
• Hirsch E, Costa C, Ciraolo E. 2007. Phosphoinositide 3-kinases as a common platform for multi-hormone signaling. J Endocrinol. 194:243–256.
   PubMed Web of Science ®Google Scholar
• Hong-Brown LQ, Brown CR, Navaratnarajah M, Huber DS, Lang CH. 2011. Alcohol-induced modulation of rictor and mTORC2 activity in C2C12 myoblasts. Alcohol Clin Exp Res. 35:1445–1453.
   Google Scholar
• Hresko RC, Mueckler M. 2005. mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. J Biol Chem. 280:40406–40416.
   PubMed Web of Science ®Google Scholar
• Jacinto E, Facchinetti V, Liu D, Soto N, Wei S, Jung SY, Huang Q, Qin J, Su B. 2006. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell. 127:125–137.
   PubMed Web of Science ®Google Scholar
• Jackson SP, Schoenwaelder SM, Goncalves I, Nesbitt WS, Yap CL, Wright CE, Kenche V, Anderson KE, Dopheide SM, Yuan Y, Sturgeon SA, Prabaharan H, Thompson PE, Smith GD, Shepherd PR, Daniele N, Kulkarni S, Abbott B, Saylik D, Jones C, Lu L, Giuliano S, Hughan SC, Angus JA, Robertson AD, Salem HH. 2005. PI3-kinase p110beta: A new target for antithrombotic therapy. Nat Med. 11:507–514.
   PubMed Web of Science ®Google Scholar
• Jean-Baptiste G, Yang Z, Khoury C, Greenwood MT. 2005. Lysophosphatidic acid mediates pleiotropic responses in skeletal muscle cells. Biochem Biophys Res Commun. 335:1155–1162.
   Google Scholar
• Jia S, Liu Z, Zhang S, Liu P, Zhang L, Lee SH, Zhang J, Signoretti S, Loda M, Roberts TM, Zhao JJ. 2008. Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis. Nature. 454:776–779.
   PubMed Web of Science ®Google Scholar
• Jiang BH, Zheng JZ, Vogt PK. 1998. An essential role of phosphatidylinositol 3-kinase in myogenic differentiation. Proc Natl Acad Sci USA. 95:14179–14183.
   PubMed Web of Science ®Google Scholar
• Jiang BH, Aoki M, Zheng JZ, Li J, Vogt PK. 1999. Myogenic signaling of phosphatidylinositol 3-kinase requires the serine-threonine kinase Akt/protein kinase B. Proc Natl Acad Sci USA. 96:2077–2081.
   PubMed Web of Science ®Google Scholar
• Karalaki M, Fili S, Philippou A, Koutsilieris M. 2009. Muscle regeneration: Cellular and molecular events. In Vivo. 23:779–796.
   PubMed Web of Science ®Google Scholar
• Knight ZA, Gonzalez B, Feldman ME, Zunder ER, Goldenberg DD, Williams O, Loewith R, Stokoe D, Balla A, Toth B, Balla T, Weiss WA, Williams RL, Shokat KM. 2006. A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling. Cell. 125:733–747.
   PubMed Web of Science ®Google Scholar
• Kuang S, Rudnicki MA. 2008. The emerging biology of satellite cells and their therapeutic potential. Trends Mol Med. 14:82–91.
   PubMed Web of Science ®Google Scholar
• Kuang S, Gillespie MA, Rudnicki MA. 2008. Niche regulation of muscle satellite cell self-renewal and differentiation. Cell Stem Cell. 2:22–31.
   PubMed Web of Science ®Google Scholar
• Lin ME, Herr DR, Chun J. 2010. Lysophosphatidic acid (LPA) receptors: Signaling properties and disease relevance. Prostaglandins Other Lipid Mediat. 91:130–138.
   PubMed Web of Science ®Google Scholar
• Maier U, Babich A, Nurnberg B. 1999. Roles of non-catalytic subunits in gbetagamma-induced activation of class I phosphoinositide 3-kinase isoforms beta and gamma. J Biol Chem. 274:29311–29317.
   PubMed Web of Science ®Google Scholar
• Manning BD, Cantley LC. 2007. AKT/PKB signaling: Navigating downstream. Cell. 129:1261–1274.
   PubMed Web of Science ®Google Scholar
• Maroulakou IG, Oemler W, Naber SP, Klebba I, Kuperwasser C, Tsichlis PN. 2008. Distinct roles of the three Akt isoforms in lactogenic differentiation and involution. J Cell Physiol. 217:468–477.
   PubMed Web of Science ®Google Scholar
• Marques M, Kumar A, Cortes I, Gonzalez-Garcia A, Hernandez C, Moreno-Ortiz MC, Carrera AC. 2008. Phosphoinositide 3-kinases p110alpha and p110beta regulate cell cycle entry, exhibiting distinct activation kinetics in G1 phase. Mol Cell Biol. 28:2803–2814.
   PubMed Web of Science ®Google Scholar
• Marques M, Kumar A, Poveda AM, Zuluaga S, Hernandez C, Jackson S, Pasero P, Carrera AC. 2009. Specific function of phosphoinositide 3-kinase beta in the control of DNA replication. Proc Natl Acad Sci USA. 106:7525–7530.
   PubMed Web of Science ®Google Scholar
• Matheny RWJr, Adamo ML. Role of Akt isoforms in IGF-I-mediated signaling and survival in myoblasts. Biochem Biophys Res Commun. 2009a; 389:117–121.
   Google Scholar
• Matheny RWJr, Adamo ML. 2009. Effects of PI3K catalytic subunit and Akt isoform deficiency on mTOR and p70S6K activation in myoblasts. Biochem Biophys Res Commun. 390:252–257.
   PubMedGoogle Scholar
• Matheny RWJr, Adamo ML. 2010. PI3K p110 alpha and p110 beta have differential effects on Akt activation and protection against oxidative stress-induced apoptosis in myoblasts. Cell Death Differ. 17:677–688.
   PubMedGoogle Scholar
• Matheny RWJr, Nindl BC. 2011. Loss of IGF-IEa or IGF-IEb impairs myogenic differentiation. Endocrinology. 152:1923–1934.
   Google Scholar
• Mauro A. 1961. Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol. 9:493–495.
   PubMed Web of Science ®Google Scholar
• Minetti GC, Feige JN, Rosenstiel A, Bombard F, Meier V, Werner A, Bassilana F, Sailer AW, Kahle P, Lambert C, Glass DJ, Fornaro M. 2011. Galphai2 signaling promotes skeletal muscle hypertrophy, myoblast differentiation, and muscle regeneration. Sci Signal. 4:ra80.
   PubMed Web of Science ®Google Scholar
• Moolenaar WH. 1995. Lysophosphatidic acid, a multifunctional phospholipid messenger. J Biol Chem. 270:12949–12952.
   PubMed Web of Science ®Google Scholar
• Murga C, Fukuhara S, Gutkind JS. 2000. A novel role for phosphatidylinositol 3-kinase beta in signaling from G protein-coupled receptors to Akt. J Biol Chem. 275:12069–12073.
   PubMedGoogle Scholar
• Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, Yancopoulos GD, Glass DJ. 2001. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol. 3:1009–1013.
   PubMed Web of Science ®Google Scholar
• Rotwein P, Wilson EM. 2009. Distinct actions of Akt1 and Akt2 in skeletal muscle differentiation. J Cell Physiol. 219:503–511.
   PubMedGoogle Scholar
• Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, Yan H, Gazdar A, Powell SM, Riggins GJ, Willson JK, Markowitz S, Kinzler KW, Vogelstein B, Velculescu VE. 2004. High frequency of mutations of the PIK3CA gene in human cancers. Science. 304:554.
   PubMed Web of Science ®Google Scholar
• Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. 2005. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science. 307:1098–1101.
   PubMed Web of Science ®Google Scholar
• Scheid MP, Marignani PA, Woodgett JR. 2002. Multiple phosphoinositide 3-kinase-dependent steps in activation of protein kinase B. Mol Cell Biol. 22:6247–6260.
   PubMed Web of Science ®Google Scholar
• Shah BH, Neithardt A, Chu DB, Shah FB, Catt KJ. 2006. Role of EGF receptor transactivation in phosphoinositide 3-kinase-dependent activation of MAP kinase by GPCRs. J Cell Physiol. 206:47–57.
   Google Scholar
• Sharples AP, Stewart CE. 2011. Myoblast models of skeletal muscle hypertrophy and atrophy. Curr Opin Clin Nutr Metab Care. 14:230–236.
   Google Scholar
• Shi X, Garry DJ. 2006. Muscle stem cells in development, regeneration, and disease. Genes Dev. 20:1692–1708.
   PubMed Web of Science ®Google Scholar
• Shu L, Houghton PJ. 2009. The mTORC2 complex regulates terminal differentiation of C2C12 myoblasts. Mol Cell Biol. 29:4691–4700.
   PubMed Web of Science ®Google Scholar
• Soliman GA, Acosta-Jaquez HA, Dunlop EA, Ekim B, Maj NE, Tee AR, Fingar DC. 2010. mTOR Ser-2481 autophosphorylation monitors mTORC-specific catalytic activity and clarifies rapamycin mechanism of action. J Biol Chem. 285:7866–7879.
   PubMed Web of Science ®Google Scholar
• Stokoe D, Stephens LR, Copeland T, Gaffney PR, Reese CB, Painter GF, Holmes AB, McCormick F, Hawkins PT. 1997. Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science. 277:567–570.
   PubMed Web of Science ®Google Scholar
• Surucu B, Bozulic L, Hynx D, Parcellier A, Hemmings BA. 2008. In vivo analysis of protein kinase B (PKB)/Akt regulation in DNA-PKcs-null mice reveals a role for PKB/Akt in DNA damage response and tumorigenesis. J Biol Chem. 283:30025–30033.
   PubMed Web of Science ®Google Scholar
• Toker A, Newton AC. 2000. Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site. J Biol Chem. 275:8271–8274.
   PubMed Web of Science ®Google Scholar
• Tureckova J, Wilson EM, Cappalonga JL, Rotwein P. 2001. Insulin-like growth factor-mediated muscle differentiation: Collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin. J Biol Chem. 276:39264–39270.
   PubMed Web of Science ®Google Scholar
• Utermark T, Rao T, Cheng H, Wang Q, Lee SH, Wang ZC, Iglehart JD, Roberts TM, Muller WJ, Zhao JJ. 2012. The p110alpha and p110beta isoforms of PI3K play divergent roles in mammary gland development and tumorigenesis. Genes Dev. 26:1573–1586.
   PubMed Web of Science ®Google Scholar
• Vanhaesebroeck B, Waterfield MD. 1999. Signaling by distinct classes of phosphoinositide 3-kinases. Exp Cell Res. 253:239–254.
   PubMed Web of Science ®Google Scholar
• Vogt PK, Gymnopoulos M, Hart JR. 2009. PI3-kinase and cancer: Changing accents. Curr Opin Genet Dev. 19:12–17.
   PubMed Web of Science ®Google Scholar
• Warfel NA, Niederst M, Newton AC. 2011. Disruption of the interface between the pleckstrin homology (PH) and kinase domains of Akt protein is sufficient for hydrophobic motif site phosphorylation in the absence of mTORC2. J Biol Chem. 286:39122–39129.
   Google Scholar
• Wick MJ, Dong LQ, Riojas RA, Ramos FJ, Liu F. 2000. Mechanism of phosphorylation of protein kinase B/Akt by a constitutively active 3-phosphoinositide-dependent protein kinase-1. J Biol Chem. 275:40400–40406.
   PubMed Web of Science ®Google Scholar
• Winter JN, Jefferson LS, Kimball SR. 2011. ERK and Akt signaling pathways function through parallel mechanisms to promote mTORC1 signaling. Am J Physiol Cell Physiol. 300:C1172–C1180.
   PubMed Web of Science ®Google Scholar
• Winter JN, Fox TE, Kester M, Jefferson LS, Kimball SR. 2010. Phosphatidic acid mediates activation of mTORC1 through the ERK signaling pathway. Am J Physiol Cell Physiol. 299:C335–C344.
   PubMed Web of Science ®Google Scholar
• Xie X, Zhang D, Zhao B, Lu M-K, You M, Condorelli G, Wang C-Y, Guan K-L. 2011. IκB kinase ϵ and TANK-binding kinase 1 activate AKT by direct phosphorylation. Proc Natl Acad Sci USA. 108:6474–6479.
   PubMed Web of Science ®Google Scholar
• Yart A, Roche S, Wetzker R, Laffargue M, Tonks N, Mayeux P, Chap H, Raynal P. 2002. A function for phosphoinositide 3-kinase beta lipid products in coupling beta gamma to Ras activation in response to lysophosphatidic acid. J Biol Chem. 277:21167–21178.
   PubMedGoogle Scholar
• Yip SC, El-Sibai M, Hill KM, Wu H, Fu Z, Condeelis JS, Backer JM. 2004. Over-expression of the p110beta but not p110alpha isoform of PI 3-kinase inhibits motility in breast cancer cells. Cell Motil Cytoskeleton. 59:180–188.
   PubMedGoogle Scholar
• Zhao JJ, Cheng H, Jia S, Wang L, Gjoerup OV, Mikami A, Roberts TM. 2006. The p110alpha isoform of PI3K is essential for proper growth factor signaling and oncogenic transformation. Proc Natl Acad Sci USA. 103:16296–16300.
   PubMed Web of Science ®Google Scholar
• Zinzalla V, Stracka D, Oppliger W, Hall MN. 2011. Activation of mTORC2 by association with the ribosome. Cell. 144:757–768.
   PubMed Web of Science ®Google Scholar